BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,806,760 | -51.8% | 710,301 | -41.8% | 0.01% | -51.9% |
| Q2 2023 | $55,634,273 | +25269.6% | 1,221,121 | -77.4% | 0.03% | -78.4% |
| Q1 2023 | $219,295 | +16.2% | 5,406,665 | +46.0% | 0.12% | +20.2% |
| Q4 2022 | $188,750 | -99.9% | 3,703,166 | -44.7% | 0.10% | -51.2% |
| Q3 2022 | $360,987,000 | +161.7% | 6,702,329 | +212.0% | 0.21% | +147.7% |
| Q2 2022 | $137,963,000 | +56.3% | 2,147,953 | +88.6% | 0.09% | +83.0% |
| Q1 2022 | $88,296,000 | -73.6% | 1,138,723 | -70.7% | 0.05% | -72.2% |
| Q4 2021 | $334,033,000 | +50.6% | 3,891,345 | +41.2% | 0.17% | +28.0% |
| Q3 2021 | $221,735,000 | +101.4% | 2,756,871 | +101.6% | 0.13% | +94.1% |
| Q2 2021 | $110,075,000 | +376.6% | 1,367,380 | +399.3% | 0.07% | +325.0% |
| Q1 2021 | $23,097,000 | -40.6% | 273,850 | -43.5% | 0.02% | -42.9% |
| Q4 2020 | $38,913,000 | -29.8% | 484,955 | -29.6% | 0.03% | -58.8% |
| Q3 2020 | $55,394,000 | +19.9% | 688,809 | +28.4% | 0.07% | +7.9% |
| Q2 2020 | $46,191,000 | -62.5% | 536,473 | -64.7% | 0.06% | -77.3% |
| Q1 2020 | $123,255,000 | +28.9% | 1,518,099 | +32.7% | 0.28% | +132.8% |
| Q4 2019 | $95,652,000 | +169.8% | 1,143,889 | +182.3% | 0.12% | +112.5% |
| Q3 2019 | $35,447,000 | +67.1% | 405,266 | +56.4% | 0.06% | +75.0% |
| Q2 2019 | $21,217,000 | -82.8% | 259,060 | -82.9% | 0.03% | -82.7% |
| Q1 2019 | $123,072,000 | +102.8% | 1,513,606 | +64.2% | 0.18% | +94.7% |
| Q4 2018 | $60,677,000 | -14.8% | 921,858 | -0.3% | 0.10% | +9.2% |
| Q3 2018 | $71,247,000 | -60.7% | 924,206 | -62.4% | 0.09% | -63.3% |
| Q2 2018 | $181,412,000 | +9.3% | 2,456,816 | -3.7% | 0.24% | +7.2% |
| Q1 2018 | $165,939,000 | +1762.2% | 2,551,343 | +1750.6% | 0.22% | +1600.0% |
| Q4 2017 | $8,911,000 | -79.9% | 137,862 | -80.5% | 0.01% | -80.9% |
| Q3 2017 | $44,389,000 | -35.0% | 707,395 | -37.3% | 0.07% | -44.3% |
| Q2 2017 | $68,301,000 | +14.0% | 1,128,194 | -2.4% | 0.12% | +10.9% |
| Q1 2017 | $59,935,000 | -28.5% | 1,155,706 | -38.9% | 0.11% | -37.5% |
| Q4 2016 | $83,840,000 | +28.8% | 1,890,834 | +38.3% | 0.18% | +61.5% |
| Q3 2016 | $65,074,000 | -23.1% | 1,367,094 | -27.0% | 0.11% | -43.8% |
| Q2 2016 | $84,676,000 | +48.5% | 1,872,536 | +34.9% | 0.19% | +36.6% |
| Q1 2016 | $57,032,000 | +541.0% | 1,388,323 | +495.2% | 0.14% | +647.4% |
| Q4 2015 | $8,898,000 | -32.3% | 233,242 | -41.7% | 0.02% | -24.0% |
| Q3 2015 | $13,146,000 | -58.8% | 400,182 | -12.4% | 0.02% | -58.3% |
| Q2 2015 | $31,931,000 | -46.8% | 456,614 | -47.9% | 0.06% | -46.4% |
| Q1 2015 | $60,053,000 | +981.8% | 876,688 | +1033.6% | 0.11% | +700.0% |
| Q3 2014 | $5,551,000 | -91.5% | 77,339 | -91.5% | 0.01% | -92.3% |
| Q2 2014 | $65,619,000 | +4746.3% | 907,589 | +4832.5% | 0.18% | +4450.0% |
| Q1 2014 | $1,354,000 | -39.8% | 18,400 | -43.1% | 0.00% | -42.9% |
| Q4 2013 | $2,250,000 | -84.3% | 32,355 | -85.2% | 0.01% | -84.8% |
| Q3 2013 | $14,355,000 | -65.5% | 218,524 | -63.6% | 0.05% | -63.8% |
| Q2 2013 | $41,577,000 | – | 600,213 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |